Firefly Neuroscience
AIFF
9 hedge funds and large institutions have $271K invested in Firefly Neuroscience in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
61% more capital invested
Capital invested by funds: $168K → $271K (+$103K)
0.36% less ownership
Funds ownership: 1.65% → 1.3% (-0.36%)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LI
Lafayette Investments
Ashton,
Maryland
|
-$21.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.03K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$114 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Pathstone Holdings
Englewood,
New Jersey
| $86.5K | – | – | – |
|
|
TWM
2
Trueblood Wealth Management
Lima,
Ohio
| $55.4K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $40.3K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $38.4K | – | – | – |
|
|
WPW
5
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $34.6K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $10.5K | -$8.03K | -1,197 | -54% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4.94K | -$11.9K | -1,777 | -79% |
|
8
Wells Fargo
San Francisco,
California
| $42 | – | – | – |
|
|
CA
9
Continuum Advisory
Eagle,
Idaho
| $3 | – | – | – |
|
|
LI
10
Lafayette Investments
Ashton,
Maryland
| – | -$21.1K | -4,160 | Closed |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$114 | -17 | -68% |
|
AIFF Hedge Fund Activity: Q1 2024 in Review
9 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q1 2024, worth a combined $271K — up 61% from $168K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AIFF and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest seller was Lafayette Investments, exiting entirely with an estimated $21.1K sold.
- 9 institutional investors held Firefly Neuroscience (AIFF) as of Q1 2024, down from 10 in Q4 2023.
- Funds reported $271K of Firefly Neuroscience stock for Q1 2024, up 61% quarter-over-quarter.
- 0 funds opened new Firefly Neuroscience positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Firefly Neuroscience seller in Q1 2024 was Lafayette Investments, an estimated $21.1K sold.
Based on aggregated 13F filings for Q1 2024.